• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Richard Gaynor - Articles and news items

Lilly-Logo

Updates on three of six ongoing Phase III Ramucirumab trials to be presented

Industry news, News / 14 May 2012 / Eli Lilly and Company

Eli Lilly and Company will present data from several molecules…

Lilly-Logo

Lilly targets faulty c-MET receptor in cancer research studies presented at AACR Meeting

Industry news, News / 2 April 2012 / Eli Lilly and Company

Studies provided basis for ongoing Phase I, II studies in gastric, other cancers…

Lilly-Logo

Lilly oncology reveals findings from study of JAK2 inhibitor for blood cancers at ASH meeting

Industry news, News / 12 December 2011 / Eli Lilly and Company

Data from an oncology pipeline molecule announced at the ASH meeting…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +